WEATHER ALERT
1 day ago
Sarepta will resume gene therapy shipments after FDA review of recent patient death
Read full article: Sarepta will resume gene therapy shipments after FDA review of recent patient deathShares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping its gene therapy.